SK

Chemical Engineer in rare disease biotech. Catalyst trader. Always monitoring options flow.

[SK @flutestep]

$AKRO $ETNB both acquired within 3 months of this 🔥🔥

[SK @flutestep]

My greed sickens me

[SK @flutestep]

@Investorclimber We ride.

[SK @flutestep]

@biofeed

[SK @flutestep]

@bullishbruk @US_FDA @FDA_KyleD @BagholderQuotes

[SK @flutestep]

@Investorclimber Yes sir. There’s too much juice left to squeeze. Downside should be sub $1. I trimmed some 7/31s earlier but holding these

[SK @flutestep]

@biofeed Price action pete final boss

[SK @flutestep]

@BOSSTRADING0 Next line one min later has contract and IV down a lot with spot up. These are sells.

[SK @flutestep]

@AnotherKoreanX Does the 40x down strat still work if the sponsor committed fraud?

[SK @flutestep]

@biofeed I was there

[SK @flutestep]

@biofeed The risk of the short leg zeroing out the entire trade if unequivocally neg adcomm vs.

the reward of getting a small discount on the trade

I don’t like it. Very specific bet on mixed adcomm -> CRL. Surely better ways to play it.

[SK @flutestep]

@biofeed

[SK @flutestep]

@justalexoki

[SK @flutestep]

@BlakeTalin @vulturetrades came literally one minute before he tweeted. this clown's only trading strategy is to fill random illiquid options, then lie about his entry to his followers to dump for penny profits as they pile into it. its very easy to detect every time.

[SK @flutestep]

@john_hersc79276 @biofeed @NoseRubInvest @drsprs @CloisterRes based on current pricing in the chain and expected downside on CRL... premiums (IMO) are very, very reasonable. whether one wants to hedge or take outright bearish positioning.

[SK @flutestep]

@biofeed @AaronRosenblum5 not sure about intentional. similar thing happened before last CRL. puts were way too cheap until closer to the event where demand ramped up. i suspect the same thing will play out here

[SK @flutestep]

@CloisterRes

[☕️ @biofeed]

JUL 31 8P

[SK @flutestep]

@ezmoneymonty Shockingly majority of the 260s haven’t closed , and stock actually being held up well. Rumor might have some legs .

[SK @flutestep]

$ASND surprise surprise

[Marc Lehman @markflowchatter]

on $ASND in final talks to be bought out --high premium --BETAVILLE

[SK @flutestep]

@biofeed go revisit your med school notes bruv